Risedronate to Prevent Bone Loss After Sleeve Gastrectomy: Study Design and Feasibility Report of a Pilot Randomized Controlled Trial

Risedronate to Prevent Bone Loss After Sleeve Gastrectomy: Study Design and Feasibility Report of a Pilot Randomized Controlled Trial

ABSTRACT Mounting evidence implicates bariatric surgery as a cause of increased skeletal fragility and fracture risk. Bisphosphonate therapy reduces osteoporotic fracture risk and may be effective in minimizing bone loss associated with bariatric surgery. The main objective of this pilot randomized...

Full description

Bibliographic Details
Main Authors: Ashlyn A Swafford, Jamy D Ard, Daniel P Beavers, Peri C Gearren, Adolfo Z Fernandez, Sherri A Ford, Katelyn A Greene, Daniel E Kammire, Beverly A Nesbit, Kylie K Reed, Ashley A Weaver, Kristen M Beavers
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:JBMR Plus
Subjects:
DXA
ANTIRESORPTIVES
FRACTURE PREVENTION
CLINICAL TRIALS
BONE QUANTITATIVE COMPUTED TOMOGRAPHY
Online Access:https://doi.org/10.1002/jbm4.10407

Internet

https://doi.org/10.1002/jbm4.10407

Similar Items